NSIS-B.CO
NSIS-B.CO
DK0060336014
Novonesis (Novozymes A/S) B
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
202.91B EUR
192.51B EUR
178.33B EUR
190B EUR
Enterprise Value
206.08B EUR
195.27B EUR
181.22B EUR
189.72B EUR
Valuation Multiples
Trailing P/E
42.82x
390.02x
388.78x
426.39x
Forward P/E
24.23x
--
--
--
Price to Sales
47.22x
59.56x
56.9x
61.43x
Price to Book
2.44x
17.26x
16.33x
17.5x
EV/Revenue
47.96x
60.42x
57.82x
61.35x
EV/EBITDA
128.04x
291.28x
280.05x
290.45x
Price to FCF (P/FCF)
279.22x
471.15x
431.38x
486.43x
EV/FCF
283.58x
477.91x
438.36x
485.73x
FCF Yield
0.36%
0.21%
0.23%
0.21%
ende